Tag: Perseris

In July 2018, the U.S. Food and Drug Administration (FDA) approved Risperdal Perseris (risperidone) for the treatment of schizophrenia in adults. This approval was based on clinical trials demonstrating its efficacy as a once-monthly, subcutaneous, extended-release injectable.

The wholesale acquisition cost (WAC) for Perseris can be over $2,800 per monthly dose, making it a very expensive medication for many patients. Understanding **how much does Perseris cost** requires looking beyond this sticker price to see the actual out-of-pocket expenses and available savings options.

Medication non-adherence rates in schizophrenia are estimated to be around 50%, making long-acting injectables a crucial treatment option [1.6.3]. While both medications contain the same active drug, the answer to 'Is Perseris the same as Risperdal Consta?' lies in their significant differences in administration and formulation.

In July 2024, pharmaceutical manufacturer Indivior announced its decision to stop all sales and marketing activities for its schizophrenia drug, Perseris® (risperidone). For patients currently on this long-acting injectable medication, understanding the implications of whether **Is Perseris still available?** is crucial for ensuring a seamless transition and continuity of care.

In the United States, adherence rates for oral antipsychotics can be as low as 40% to 60% [1.7.5]. To address this, long-acting injectables like Perseris offer a different approach, but a key question for healthcare providers is: **Is Perseris IM or subq?**

In a July 2024 announcement, pharmaceutical company Indivior revealed it would cease promoting and selling its schizophrenia medication, Perseris. This decision, driven by market pressures and financial viability concerns rather than any safety or efficacy issues, left many asking: **why was Perseris discontinued**?

Perseris (risperidone) is a long-acting injectable suspension indicated for the treatment of schizophrenia in adults and is designed for once-monthly subcutaneous administration. Crucially, the process of **how do you inject Perseris** requires adherence to a specific protocol that must be performed exclusively by a trained healthcare professional.

As the first once-monthly, long-acting injectable risperidone, Perseris requires specific handling and administration procedures by a healthcare provider. This guide will detail **how is Perseris administered**, from preparation to patient aftercare, ensuring the crucial steps are followed for proper depot formation and sustained release.